BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7296480)

  • 1. Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma.
    Green AA; Hayes FA; Hustu HO
    Cancer; 1981 Nov; 48(10):2310-7. PubMed ID: 7296480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total-body sequential segmental irradiation and combination chemotherapy for children with disseminated neuroblastoma.
    Green AA; Hustu HO; Palmer R; Pinkel D
    Cancer; 1976 Dec; 38(6):2250-7. PubMed ID: 1000465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: experience with 100 patients.
    Kushner BH; Helson L
    J Clin Oncol; 1987 Nov; 5(11):1746-51. PubMed ID: 3316512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study.
    McWilliams NB; Hayes FA; Green AA; Smith EI; Nitschke R; Altshuler GA; Shuster JJ; Castleberry RP; Vietti TJ
    Med Pediatr Oncol; 1995 Mar; 24(3):176-80. PubMed ID: 7838039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined chemotherapy of neuroblastoma. 1st results in 40 children with metastatic form].
    Zucker JM; Mercier JC
    Arch Fr Pediatr; 1976; 33(6):555-67. PubMed ID: 949221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of advanced neuroblastoma: does adriamycin contribute?
    Ninane J; Pritchard J; Malpas JS
    Arch Dis Child; 1981 Jul; 56(7):544-8. PubMed ID: 7271289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma.
    Hayes FA; Green AA; Mauer AM
    Cancer Res; 1977 Oct; 37(10):3766-70. PubMed ID: 908020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?
    Bernard JL; Philip T; Zucker JM; Frappaz D; Robert A; Margueritte G; Boilletot A; Philippe N; Lutz P; Roche H
    J Clin Oncol; 1987 Dec; 5(12):1952-9. PubMed ID: 3681378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.
    Leikin S; Bernstein I; Evans A; Finklestein J; Hittle R; Klemperer M
    Cancer Chemother Rep; 1975; 59(5):1015-8. PubMed ID: 1106842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
    Valteau-Couanet D; Michon J; Boneu A; Rodary C; Perel Y; Bergeron C; Rubie H; Coze C; Plantaz D; Bernard F; Chastagner P; Bouzy J; Hartmann O
    J Clin Oncol; 2005 Jan; 23(3):532-40. PubMed ID: 15659499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: a phase II study from the Société Française d'Oncologie Pédiatrique.
    Méresse V; Vassal G; Michon J; De Cervens C; Courbon B; Rubie H; Perel Y; Landman J; Chastagnier P; De Valck C
    J Clin Oncol; 1993 Apr; 11(4):630-7. PubMed ID: 8478658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
    Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
    J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
    Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
    J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
    Castleberry RP; Kun LE; Shuster JJ; Altshuler G; Smith IE; Nitschke R; Wharam M; McWilliams N; Joshi V; Hayes FA
    J Clin Oncol; 1991 May; 9(5):789-95. PubMed ID: 2016621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
    Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
    J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
    Mora J; Cruz O; Lavarino C; Rios J; Vancells M; Parareda A; Salvador H; Suñol M; Carrasco R; Guillen A; Mañé S; de Torres C
    Clin Transl Oncol; 2015 Jul; 17(7):521-9. PubMed ID: 25596034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.
    Kushner BH; O'Reilly RJ; LaQuaglia M; Cheung NK
    Cancer; 1990 Sep; 66(6):1095-100. PubMed ID: 2400963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.